Managing Adverse Events With Oral SERD Therapy and Promoting Treatment Adherence and Persistence

Content Format:

Case Challenge

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

0.25
Individualizing Therapy for Metastatic Breast Cancer: Oral SERD Therapy

Content Format:

Case Challenge

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

0.25
Applying Evidence-Based Strategies to Improve Outcomes in HER2-Negative Early Breast Cancer

Content Format:

Video

Credit Type:

ACPE-P

Credits:

1.00
Key Takeaways in the Management of HER2-Negative Early Breast Cancer: Focus on Treating Patients With Pathogenic Variants in Germline BRCA

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Key Takeaways in the Management of HER2-Negative Early Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Applying Evidence-Based Strategies to Improve Outcomes in HER2-Negative Early Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Expert Answers to FAQs on HER2-, HER3-, and TROP-2–Directed ADCs for Pharmacists

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Maximizing Efficacy and Minimizing Toxicity of ADCs Targeting HER2, HER3, and TROP-2: Strategies for Oncology Pharmacists

Content Format:

Video

Credit Type:

ACPE-P

Credits:

1.00
Maximizing Efficacy and Minimizing Toxicity of ADCs Targeting HER2, HER3, and TROP-2: Strategies for Oncology Pharmacists

Content Format:

Slideset

Credit Type:

--

Credits:

--
The Pharmacist’s Role in Improving Medication Adherence to Oral SERD Therapy in HR+/HER2- Breast Cancer

Content Format:

Clinical Thought

Credit Type:

ACPE

Credits:

0.25
Our Experiences With the Expanded Role of BRCA Testing and Adjuvant PARP Inhibition in Early Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
BRCA Testing and Adjuvant Therapy in Early Breast Cancer: Experiences and Challenges

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Current Essential Testing in Early Breast Cancer

Content Format:

Video

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
BRCA Testing and the Role of PARP Inhibition in Early Breast Cancer: A Multidisciplinary Roundtable

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Initiation of Adjuvant Olaparib and Recommended Monitoring

Content Format:

Slideset

Credit Type:

--

Credits:

--
Importance of BRCA Testing and the Role of PARP Inhibition in Early Breast Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Best Practices for the Implementation of Clinical Advances in HR-Positive/HER2-Negative Breast Cancer

Content Format:

Multimedia

Credit Type:

ACPE

Credits:

1.00
Recent Advances in Oral Therapies for HR+/HER2- Breast Cancer: A Pharmacy Perspective

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Best Practices for the Implementation of Clinical Advances in HR-Positive/HER2-Negative Breast Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Medical Minute: Recently Approved HER2 and TROP2 Agents: Pharmacist Considerations

Content Format:

Multimedia

Credit Type:

ABIM MOC | ACPE | AMA | ANCC

Credits:

0.25